From the Division of Neurology (R.W., T.G., A.S., B. Buck, K.B.).
Division of Neurology, University of Calgary, Alberta, Canada (B.K.M., A.D., M.G., M.H.).
Stroke. 2018 Jun;49(6):1426-1433. doi: 10.1161/STROKEAHA.117.019806. Epub 2018 May 8.
In the ESCAPE trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion with Emphasis on Minimizing CT to Recanalization Times), patients with large vessel occlusions and small infarct cores identified with computed tomography (CT)/CT angiography were randomized to endovascular therapy or standard of care. CT perfusion (CTP) was obtained in some cases but was not used to select patients. We tested the hypothesis that patients with penumbral CTP patterns have higher rates of good clinical outcome.
All CTP data acquired in ESCAPE patients were analyzed centrally using a semiautomated perfusion threshold-based approach. A penumbral pattern was defined as an infarct core <70 mL, penumbral volume >15 mL, and a total hypoperfused volume:core volume ratio of >1.8. The primary outcome was good functional outcome at 90 days (modified Rankin Scale score, 0-2).
CTP was acquired in 138 of 316 ESCAPE patients. Penumbral patterns were present in 116 of 128 (90.6%) of patients with interpretable CTP data. The rate of good functional outcome in penumbral pattern patients (53 of 114; 46%) was higher than that in nonpenumbral patients (2 of 12; 17%; =0.041). In penumbral patients, endovascular therapy increased the likelihood of a good clinical outcome (34 of 58; 57%) compared with those in the control group (19 of 58; 33%; odds ratio, 2.68; 95% confidence interval, 1.25-5.76; =0.011). Only 3 of 12 nonpenumbral patients were randomized to the endovascular group, preventing an analysis of treatment effect.
The majority of patients with CTP imaging in the ESCAPE trial had penumbral patterns, which were associated with better outcomes overall. Patients with penumbra treated with endovascular therapy had the greatest odds of good functional outcome. Nonpenumbral patients were much less likely to achieve good outcomes.
在 ESCAPE 试验(强调最小化 CT 再通时间以治疗小核心和前循环近端闭塞的血管内治疗)中,通过计算机断层扫描(CT)/CT 血管造影确定存在大血管闭塞和小梗死核心的患者被随机分配到血管内治疗或标准治疗组。在某些情况下获得了 CT 灌注(CTP),但未用于选择患者。我们检验了这样一种假设,即具有缺血半暗带 CTP 模式的患者具有更高的良好临床转归率。
使用半自动基于灌注阈值的方法对所有 ESCAPE 患者的 CTP 数据进行了中心分析。缺血半暗带模式定义为梗死核心<70mL,缺血半暗带体积>15mL,总低灌注体积/核心体积比>1.8。主要结局为 90 天时的良好功能结局(改良Rankin 量表评分,0-2)。
在 316 例 ESCAPE 患者中,有 138 例获得了 CTP。在可解释 CTP 数据的 128 例患者中,有 116 例(90.6%)存在缺血半暗带模式。具有缺血半暗带模式的患者(53/114;46%)的良好功能结局率高于无缺血半暗带模式的患者(2/12;17%;=0.041)。在缺血半暗带患者中,与对照组相比(血管内治疗组 58 例中有 34 例[57%],对照组 58 例中有 19 例[33%];优势比,2.68;95%置信区间,1.25-5.76;=0.011),接受血管内治疗的患者更有可能获得良好的临床结局。仅有 3 例无缺血半暗带的患者被随机分配到血管内治疗组,这阻止了对治疗效果的分析。
在 ESCAPE 试验中,大多数接受 CTP 成像的患者存在缺血半暗带模式,总体上与更好的结局相关。接受血管内治疗的缺血半暗带患者具有良好功能结局的可能性最大。无缺血半暗带的患者更不可能获得良好的结局。